Postremission therapy for acute myeloid leukemia in the first remission
- Authors
- Kim, ST[Kim, Seung Tai]; Jung, CW[Jung, Chul Won]; Lee, J[Lee, Jeeyun]; Kwon, JM[Kwon, Jung Mi]; Oh, SY[Oh, Sung Young]; Park, BB[Park, Byeong-Bae]; Lee, HR[Lee, Hyo Rak]; Kim, HJ[Kim, Hyun Jung]; Kim, K[Kim, Kihyun]; Kim, WS[Kim, Won Seog]; Ahn, JS[Ahn, Jin Seok]; Kang, WK[Kang, Won Ki]; Park, K[Park, Keunchil]
- Issue Date
- 2007
- Publisher
- TAYLOR & FRANCIS LTD
- Keywords
- AML; allogeneic; autologous HSCT; intensive chemotherapy; postremission therapy
- Citation
- LEUKEMIA & LYMPHOMA, v.48, no.5, pp.937 - 943
- Indexed
- SCIE
SCOPUS
- Journal Title
- LEUKEMIA & LYMPHOMA
- Volume
- 48
- Number
- 5
- Start Page
- 937
- End Page
- 943
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/86185
- DOI
- 10.1080/10428190701223309
- ISSN
- 1042-8194
- Abstract
- The medical records of 99 patients with acute myeloid leukemia ( AML; except AML, M3) in the first remission from 1995 to 2004 were retrospectively reviewed. When they achieved complete remission, at first complete remission ( CR1), patients received allogeneic ( n = 23), autologous hematopoietic stem cell transplantation ( HSCT) ( n 35), or intensive chemotherapy ( n 41) according to prognostic factors and donor availability. There was an advantage in terms of event-free survival ( EFS, p = 0.0001) and overall survival ( OS, p = 0.0002) with HSCT as compared to those of intensive chemotherapy. However, the EFS and OS were not different between allogeneic HSCT and autologous HSCT. In high-risk patients, the EFS and OS of allogenic or autologous HSCT group were higher compared with those in the intensive chemotherapy group ( p < 0.01). However, there was no difference between allogeneic HSCT and autologous HSCT in terms of EFS and OS. In the intermediate- or low-risk group, there was no significant difference in the outcome according to the postremission modalities.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.